1-(2-羟基乙基)环丁醇 | 83237-27-8

• 物质功能分类: 有机原料 - 醇、酚、酚醇类化合物及衍生物
• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 1-(2-羟基乙基)环丁醇
• 英文名称: 1-hydroxy-1-(β-hydroxyethyl)cyclobutane
• 英文别名: 1-(2-hydroxyethyl)cyclobutanol；1-(1-Hydroxy-cyclobutyl)-2-hydroxy-aethan；1-(2-hydroxyethyl)cyclobutan-1-ol
• CAS: 83237-27-8
• 化学式: C₆H₁₂O₂
• 分子量: 116.16
• InChiKey: NDCSWRUDYCYSHC-UHFFFAOYSA-N

物化性质

• 沸点：
  102 °C(Press: 2 Torr)
• 密度：
  1.049 g/cm3

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  8
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-(2-羟基乙基)环丁醇 在 磷酸 作用下， 以39%的产率得到1-乙烯基环丁烯
  参考文献：
  名称：

  Preparation of 1 -vinylcyclobutene from methylenecyclobutane by the prins reaction

  摘要：

  DOI：

  10.1007/bf00954189
• 作为产物：
  描述：

  1-Oxaspiro<2.5>hexan-2-carbonsaeure-ethylester, 3,3-Trimethylen-glycidsaeure-ethyl-ester 在 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 、 乙醚 为溶剂， 反应 7.0h， 生成 1-(2-羟基乙基)环丁醇
  参考文献：
  名称：

  EP2011788

  摘要：

  公开号：

文献信息

• A new approach to the synthesis of 1-oxaspiro[4.n]alkanes and tetrahydrofurans by the 1,5-CH insertion reaction of magnesium carbenoids
  作者：Tsuyoshi Satoh、Tsukasa Yasoshima、Hitoshi Momochi

  DOI：10.1016/j.tetlet.2012.02.034

  日期：2012.4

  in high to quantitative yields via the 1,5-CH insertion reaction of generated magnesium carbenoid intermediates. When this procedure was commenced with acyclic ketones, multi-substituted tetrahydrofurans were obtained in up to a 96% yield. This procedure provides a new and good way for the synthesis of 1-oxaspiro[4.n]alkanes and tetrahydrofurans with the formation of a carbon–carbon bond between a carbenoid

  由各种环状酮以良好的总收率制备了1-烷氧基-1- [2-氯-2-（对甲苯基亚磺酰基）乙基]环烷烃。用i处理这些带有亚硫酰基的环烷烃-PrMgCl通过生成的镁类马鞭草中间体的1，5-CH插入反应，以高至定量的产率形成了1-oxaspiro [4.n]烷烃。当从无环酮开始该程序时，以高达96％的收率获得了多取代的四氢呋喃。该方法为合成1-oxaspiro [4.n]烷烃和四氢呋喃提供了一种新的良好方法，该方法可以高产率地在类胡萝卜素碳和非活性碳之间形成碳-碳键。事实证明，镁类胡萝卜素中间体中的氧原子在1,5-CH插入反应中起着非常重要的作用。
• Oxadiazolidinedione compound
  申请人：Astellas Pharma Inc.

  公开号：US07968552B2

  公开（公告）日：2011-06-28

  A compound which can be used as a pharmaceutical, particularly a insulin secretion promoter or a agent for preventing/treating disease in which GPR40 is concerned such as diabetes or the like, is provided. It was found that an oxadiazolidinedione compound which is characterized by the possession of a benzyl or the like substituent binding to the cyclic group via a linker at the 2-position of the oxadiazolidinedione ring, or a pharmaceutically acceptable salt thereof, has excellent GPR40 agonist action. In addition, since the oxadiazolidinedione compound of the present invention showed excellent insulin secretion promoting action and blood glucose level-lowering action, it is useful as an insulin secretion promoter or an agent for preventing/treating diabetes.

  提供了一种可用作药物的化合物，特别是胰岛素分泌促进剂或用于预防/治疗与GPR40相关的疾病，例如糖尿病等。发现一种噁唑烷二酮化合物，其特征在于在噁唑烷二酮环的2位通过连接基与环状基团结合的苄基或类似基团，或其药学上可接受的盐具有优异的GPR40激动剂作用。此外，由于本发明的噁唑烷二酮化合物显示出优异的胰岛素分泌促进作用和降低血糖水平的作用，因此它可用作胰岛素分泌促进剂或预防/治疗糖尿病的药物。
• SUBSTITUTED XANTHINES AND METHODS OF USE THEREOF
  申请人：Hydra Biosciences, Inc.

  公开号：US20160237089A1

  公开（公告）日：2016-08-18

  Compounds, compositions and methods are described for inhibiting the TRPC5 ion channel and disorders related to TRPC5.

  本文描述了用于抑制TRPC5离子通道及与TRPC5相关的疾病的化合物、组合物和方法。
• Oxadiazolidinedione Compound
  申请人：Negoro Kenji

  公开号：US20090186909A1

  公开（公告）日：2009-07-23

  [Problem] A compound which can be used as a pharmaceutical, particularly a insulin secretion promoter or a agent for preventing/treating disease in which GPR40 is concerned such as diabetes or the like, is provided. [Means for resolution] It was found that an oxadiazolidinedione compound which is characterized by the possession of a benzyl or the like substituent binding to the cyclic group via a linker at the 2-position of the oxadiazolidinedione ring, or a pharmaceutically acceptable salt thereof, has excellent GPR40 agonist action. In addition, since the oxadiazolidinedione compound of the present invention showed excellent insulin secretion promoting action and blood glucose level-lowering action, it is useful as an insulin secretion promoter or an agent for preventing/treating diabetes.

  【问题】提供一种可用作药物的化合物，特别是胰岛素分泌促进剂或用于预防/治疗涉及GPR40的疾病，如糖尿病等。 【解决方法】发现一种氧代唑烷二酮化合物，其特征在于在氧代唑烷二酮环的2位通过连接基与环上的苯甲基或类似取代基结合，或其药学上可接受的盐具有优异的GPR40激动剂作用。此外，由于本发明的氧代唑烷二酮化合物表现出良好的胰岛素分泌促进作用和降低血糖水平的作用，因此它可用作胰岛素分泌促进剂或预防/治疗糖尿病的药物。
• OXADIAZOLIDINEDIONE COMPOUND
  申请人：Astellas Pharma Inc.

  公开号：EP2011788A1

  公开（公告）日：2009-01-07

  [Problem] A compound which can be used as a pharmaceutical, particularly a insulin secretion promoter or a agent for preventing/treating disease in which GPR40 is concerned such as diabetes or the like, is provided. [Means for resolution] It was found that an oxadiazolidinedione compound which is characterized by the possession of a benzyl or the like substituent binding to the cyclic group via a linker at the 2-position of the oxadiazolidinedione ring, or a pharmaceutically acceptable salt thereof, has excellent GPR40 agonist action. In addition, since the oxadiazolidinedione compound of the present invention showed excellent insulin secretion promoting action and blood glucose level-lowering action, it is useful as an insulin secretion promoter or an agent for preventing/treating diabetes.

  [问题]本发明提供了一种可用作药物的化合物，特别是胰岛素分泌促进剂或预防/治疗与 GPR40 有关的疾病（如糖尿病或类似疾病）的药物。 [解决方法]研究发现，一种噁二唑烷二酮化合物或其药学上可接受的盐具有优异的 GPR40 激动剂作用，该化合物的特点是在噁二唑烷二酮环的 2 位上通过连接物具有与环基结合的苄基或类似取代基。此外，由于本发明的噁二唑烷二酮化合物具有优异的促进胰岛素分泌作用和降低血糖作用，因此可用作胰岛素分泌促进剂或预防/治疗糖尿病的药物。